⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Influenza Vaccine Market Poised to Reach $30.77 Billion by 2035 | Astute Analytica
globenewswire.com
SNY
MRNA
PFE
CSL
Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026"
prnewswire.com
AZN
NVS
MRNA
GILD
NVO
PFE
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
GDX
YQQQ
Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
prnewswire.com
ONCY
CHRS
MRNA
VIR
MRK
Clarametyx Biosciences Strengthens Scientific Advisory Board With Expert Appointments to Advance Pipeline Programs
businesswire.com
PFE
MRNA
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board
businesswire.com
RMD
MRNA
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
accessnewswire.com
MRNA
2026年世界經濟論壇：隨著世界貿易的演變，沙烏地阿拉伯正在成為「連結經濟體」
businesswire.com
AMZN
GOOG
MSFT
NVDA
IBM
ORCL
CSCO
INTC
QCOM
AMGN
GILD
BMY
MRNA
PFE
JNJ
HON
GE
BA
LMT
GD
Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies
globenewswire.com
PFE
MRNA
ASND
BVC
CAPS
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL